Home » Topics » Regulatory

Regulatory
RSS

RPR files for U.S. approval of CFC-free asthma inhalater

March 21, 1997

FDA clears midazolam for use in children

March 21, 1997

Dermagraft-TC cleared for marketing

March 20, 1997

Tretinoin gel launched in the U.S.

March 19, 1997

Roberts' Agrylin approved by FDA

March 18, 1997

ProCyte's hair transplant wound dressing approved by FDA

March 17, 1997

FDA approves Viracept for adult and pediatric use

March 17, 1997

First approval for Zomig; antimigraine agents in development

March 14, 1997

First approval for naratriptan

March 12, 1997

Pfizer initiates clinical trial in panic disorder

March 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...